--- title: "Rhabdomyosarcoma Tumors May Harbor Hidden Aggressive Cells" url: https://noti.group/rhabdomyosarcoma-tumors-may-harbor-hidden-aggressive-cells/ language: en publisher: "Noti Group" section: "Health" published: 2026-10-30T10:15:28.000Z updated: 2026-10-30T23:44:45.580Z id: 89e5c9b5-d2d0-4ba9-9df3-268537233b52 source: "ScienceDaily Health https://www.sciencedaily.com/releases/2026/10/261028232717.htm" attribution: "Link to https://noti.group/rhabdomyosarcoma-tumors-may-harbor-hidden-aggressive-cells/ and name Noti Group when you quote or summarize this story." --- # Rhabdomyosarcoma Tumors May Harbor Hidden Aggressive Cells Research suggests that some childhood cancer tumors initially classified as "lower-risk" can harbor hidden populations of highly aggressive cancer cells. A disturbing discovery has been made about certain childhood cancers, which may be more deadly than previously thought. Research suggests that some tumors initially classified as "lower-risk" can harbor hidden populations of highly aggressive cancer cells. This finding could revolutionize the way doctors identify children at risk of life-threatening cancer and tailor treatment accordingly. It's a crucial breakthrough in understanding the true nature of these diseases, which often defy predictions based on genetic markers. The study focused on rhabdomyosarcoma (RMS), an aggressive type of cancer that originates from muscle tissue and is one of the most common soft tissue cancers affecting children under 15. In the UK alone, around 55 children are diagnosed with RMS each year, a sobering statistic for families and healthcare professionals. Childhood cancers often arise from genetic changes that occur during early development, unlike many adult cancers which can develop after years of aging or exposure to environmental factors. This unique aspect of childhood cancer highlights the importance of early detection and targeted treatment. Doctors typically categorize rhabdomyosarcoma into two main groups based on the presence of a specific genetic warning sign, where two genes become fused together. This abnormal genetic combination is associated with particularly aggressive disease, but it's not the only factor at play in determining the cancer's behavior. Children whose tumors contain a particular fusion have significantly lower survival rates than those without it, even when undergoing intensive treatment. This disparity suggests that the presence of this genetic marker is not the sole determining factor in cancer aggressiveness. Researchers sought to investigate why some supposedly low-risk tumors sometimes exhibit aggressive behavior and prove fatal. To do so, they compared tumor samples from children with different forms of rhabdomyosarcoma, looking beyond traditional genetic markers used to estimate risk. The team analyzed tumor samples from 16 children, including four whose cancers lacked the fusion marker but were ultimately fatal, four with fusion-positive tumors, and eight children with fusion-negative disease who survived. This diverse sample allowed researchers to gain a more comprehensive understanding of the complex relationships between genetics and cancer behavior. Using advanced genetic analysis tools, scientists examined the tumors at an unprecedented level of detail. Single-cell RNA sequencing, for instance, measured gene activity in individual cells, enabling researchers to identify potentially hazardous cell populations that might otherwise go unnoticed. The latest research on childhood cancers has revealed an unexpected similarity between tumors classified as non-high-risk and those considered high-risk. Despite being placed in different risk categories, some of these low-risk tumors contain cells with gene activity patterns that closely resemble those found in aggressive high-risk tumors. This phenomenon is particularly striking when considering the genetic mutations involved. Researchers have identified rare genetic changes that affect many of the same cellular pathways associated with the most dangerous forms of childhood cancer. These alterations seem to push cancer cells towards a shared aggressive state, regardless of their initial classification. The findings suggest that different genetic abnormalities can ultimately lead to a similar biological condition in tumors. This means that cancers can reach a similarly hazardous state through multiple genetic routes, even if they lack the typical warning signs used to identify high-risk disease. Dr. Karin Straathof emphasizes the importance of studying individual cells within tumors. By doing so, researchers have uncovered hidden populations of aggressive cancer cells that conventional methods often miss. These cells may carry different genetic changes but converge on the same aggressive pathways, which helps explain why some children with lower-risk disease can still experience devastating outcomes. The implications of these findings could lead to more precise treatment strategies for childhood cancer. By identifying the distinctive biological signatures of aggressive cancer cells at diagnosis, doctors may be able to recognize patients who face a greater risk of relapse or death, even when standard genetic tests suggest otherwise. Researchers are exploring ways to tailor treatment plans to individual patients by identifying specific biological signatures of aggressive cancer cells. This approach could help prevent unnecessary treatment for children with genuinely lower-risk tumors, sparing them from the potential side effects of intensive chemotherapy. The team is also looking into developing therapies that target only the most dangerous cancer cells, rather than treating the entire tumor. One promising area involves immunotherapy, which uses modified immune cells to recognize and attack cancer cells. Scientists are expanding their research to include hundreds more tumor samples, hoping to uncover additional genetic changes that contribute to aggressive cancer development. The increased sample size will enable researchers to accelerate the development of personalized treatments for childhood cancers, potentially leading to better outcomes for patients. The research highlights the complexity of rhabdomyosarcoma, a cancer type previously thought to be driven by specific genetic mutations. This study reveals that aggressive tumors can share similar features despite carrying different genetic changes, challenging conventional classification systems. By understanding what these high-risk cancers have in common, researchers can gain valuable insights into their unique biology and potentially guide future treatment efforts. The discovery suggests that doctors may need to consider the broader biological state of cancer cells when identifying aggressive disease, rather than relying solely on genetic abnormalities. This distinction is crucial because tumors with different mutations can exhibit remarkably similar behavior, making it essential for clinicians to identify shared features of aggressive disease. Researchers are working towards developing more accurate risk assessments and treatments for childhood cancers by uncovering hidden aggressive behavior in tumors that have been classified as lower-risk. These findings hold promise for improving survival rates among children with the most dangerous tumors while avoiding unnecessary treatment for those whose cancer may not be life-threatening. This distinction is crucial because it allows clinicians to tailor their approach to each child's unique situation, rather than relying solely on genetic classifications. The research has been made possible through funding from various organizations, including Cancer Research UK -- Children with Cancer UK Innovation Award and Wellcome, which have provided critical support for the project. --- Source: [ScienceDaily Health](https://www.sciencedaily.com/releases/2026/10/261028232717.htm) Published by Noti Group: https://noti.group/rhabdomyosarcoma-tumors-may-harbor-hidden-aggressive-cells/